Shanghai Pharma to acquire 79% stake in Big Global, subsidiary of Dong Ying Pharma

Shanghai Pharmaceuticals will pay 615 million RMB ($100 million) to purchase a 79% stake in Big Global Limited (Hong Kong), which is owned by Dong Ying (Jiangsu) Pharmaceuticals Co. Dong Ying (Jiangsu) Pharmaceuticals specializes in muscle relaxant and cardiovascular drugs through its SFDA GMP-certified production facilities and established distribution network throughout China.

Enter your email address: Delivered by FeedBurner

Actavis to acquire Warner Chilcott

Actavis, Inc. (NYSE: ACT) has announced that it will acquire Warner Chilcott plc (NASDAQ: WCRX) in a stock-for-stock transaction valued at approximately $8.5 billion. This represents a 43 percent premium compared to Warner Chilcott's volume-weighted average trading price of $14.00 for the 30 day trading period ending on May 9, 2013 (the day before Warner Chilcott disclosed it was engaged in preliminary discussions with Actavis) and a 34 per cent premium to the Warner Chilcott closing share price on May 9, 2013 of $15.01. Warner Chilcott shareholders will receive 0.160 shares of the combined company, or $20.08 per Warner Chilcott share, based on Actavis's closing share price of $125.50 on May 17.